Explore the risk of persistence of adolescent depressive symptoms into young adulthood.
Sanofi grabs a share of Novavax’s Covid vaccine for $500M, eyeing commercialization, flu combination
Sanofi is handing Novavax $500 million upfront to bring the biotech’s Covid-19 vaccine into the fold, with dual goals of co-commercializing the current vaccine and